Interleukin-6 in hemolytic anemias: from inflammatory pathways to therapeutic targeting.

Zhao M, Yu X

Open source

DOI
10.3389/fimmu.2026.1919619
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1919619,
  title = {Interleukin-6 in hemolytic anemias: from inflammatory pathways to therapeutic targeting.},
  author = {Zhao M and Yu X},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1919619},
  url = {https://doi.org/10.3389/fimmu.2026.1919619}
}

RIS

TY  - JOUR
TI  - Interleukin-6 in hemolytic anemias: from inflammatory pathways to therapeutic targeting.
AU  - Zhao M
AU  - Yu X
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1919619
UR  - https://doi.org/10.3389/fimmu.2026.1919619
ER  - 

APA

M, Z., & X, Y. (2026). Interleukin-6 in hemolytic anemias: from inflammatory pathways to therapeutic targeting.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1919619

Source records